News | February 14, 2023
NATCO files generic Olaparib Tablets in USA
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Technology and innovation play a pivotal role towards enhancing healthcare systems, increasing access to healthcare services, and reducing costs of therapies and consultations
Experts’ conclave to pave holistic approach to cancer management
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.
The AGE1.CR.pIX cell line is derived from primary cells of a duck embryo and was designed to comply with health authority guidelines
AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”
APAC to see a reduction in imported surgical robotics
Exceeding the target of 1.50 lakh Ayushman Bharat - Health & Wellness Centres (AB-HWC) by 31 December, 2022, more than 1.54 lakh Sub Health Centres and Primary Health Centres have been transformed as AB-HWCs
Subscribe To Our Newsletter & Stay Updated
